Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,471 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05707975Recruiting
Support for teens with eco-anxiety and suicidal thoughts
This trial studies a program to help adolescents who feel eco-anxiety (distress about environmental issues) and may also be at risk for suicidal thoughts. It may help by testing an approach for teens during a hospital stay in child mental health care.
Bron, RhoneAges 12–16 - NCT07509749RecruitingPhase 2
New treatments for severe acute GVHD after stem cell transplant
This trial tests new medications for people who develop severe acute graft-versus-host disease (aGVHD) within 100 days after their first stem cell transplant. The goal is to find safer, more effective ways to control aGVHD and improve recovery.
BeijingAges 14 years+ - NCT06761209Recruiting
Autoantibody negativity and autoimmune hepatitis severity
This trial checks if the absence of certain antibodies in autoimmune hepatitis (AIH) is linked to more severe disease. It may help doctors better understand and treat AIH.
Paris, FranceAges 18 years+ - NCT07503028Enrolling by invitationEarly Phase 1
Stem cell therapy for severe low blood sugar in diabetes
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
Hefei, AnhuiAges 18–70 - NCT07502664Recruiting
A study on vision and navigation in inherited retinal disease
This study is looking at how people with inherited retinal disease that affects peripheral vision see and move around. It will test a new way to measure vision and navigation to see if it can help doctors understand how the disease affects daily life.
Irvine, CaliforniaAges 18 years+ - NCT06690112Recruiting
Early drain removal after stomach cancer surgery
This pilot study tests whether it is safe to remove the surgical drain early in patients with a specific amount of output after stomach cancer surgery. It may help reduce discomfort and hospital stay for patients whose drain output is moderate.
SeoulAges 18–79 - NCT07499466Recruiting
Peer support for breastfeeding mothers facing hardship
This study tests whether extra support from another mother (a peer supporter) can help women who are facing serious financial or social challenges successfully breastfeed. If you are a new mother with a baby at HFME, want to breastfeed, and are struggling economically, this program may offer free, friendly help.
Bron, FranceAges 18 years+ - NCT07501858Recruiting
H. pylori and insulin resistance in metabolic syndrome
This study looks at whether a common stomach infection (H. pylori) affects insulin resistance in people with metabolic syndrome. It uses simple tests like a breath test, stool sample, and blood draw to check if treating the infection could help improve metabolic health.
Novosibirsk, Novosibirsk OblastAges 18–65 - NCT07504731Recruiting
Effect of body position and breathing support on lung function
This study tests how changing a patient's body tilt and adjusting a ventilator's settings can help open up collapsed parts of the lungs. It may help patients with severe lung failure.
Nanjing, JiangsuAges 18 years+ - NCT07500376Recruiting
Nutrition and Muscle Health in Lung Cancer Surgery
This study looks at how nutrition and muscle health before lung cancer surgery can affect recovery. It tests whether checking these factors can help predict and improve outcomes after surgery.
Samsun, SamsunAges 18 years+ - NCT05642182RecruitingPhase 1
Study drug trial for mild to moderate plaque psoriasis
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
Pompano Beach, FloridaAges 18 years+ - NCT07491172RecruitingPhase 1
Trial of CTX310 for stubborn high cholesterol and fats
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
Hialeah, FloridaAges 18–75 - NCT05686525Recruiting
TUMT vs PAE to ease severe urinary symptoms from an enlarged prostate
This trial compares two catheter-based treatments—TUMT and PAE—to see which better reduces severe urinary symptoms caused by an enlarged prostate (BPH). It may help you choose a treatment option if medicines are not suitable or you still have significant symptoms.
Copenhagen, Copenhagen NAges 40 years+ - NCT06770621Recruiting
Glucagon response study in new type 1 diabetes
This study looks at how the body makes glucagon (a hormone that raises blood sugar) in children and teens with new type 1 diabetes. It aims to understand why some people may have dangerous low blood sugars, so doctors can better prevent them in the future.
Brussels, Woluwe-saint-lambertAges 2–30 - NCT07488936Recruiting
How low back pain types affect pain and quality of life after failed back surgery
This study looks at how different types of low back pain affect pain severity and quality of life in people who still have pain after back surgery. It aims to help doctors better understand and treat your pain.
Konya, SelçukluAges 18 years+ - NCT07486401Recruiting
Blood eosinophil-guided asthma care in primary care
This trial tests whether using a blood test (eosinophil count) to guide asthma treatment works better than usual care for people with mild to moderate asthma. If you have asthma and are on step 1-3 treatment, this study could help improve your symptom control.
SingaporeAges 21–65 - NCT07484607Recruiting
Study on infections and treatments in cystic fibrosis exacerbations
This study looks at how lung infections and inflammation affect people with cystic fibrosis during severe flare-ups. It aims to understand which antibiotics work best and why, so your care team can choose the right treatment for you.
CardiffAges 16 years+ - NCT07485361Recruiting
Brain scanning in disorders of consciousness
This trial uses a portable brain scanner (fNIRS) to study brain activity in people with disorders of consciousness, like coma or minimally conscious states. It may help doctors better understand and track recovery in these patients. Healthy volunteers are also needed as a comparison group.
Los Angeles, CaliforniaAges 18 years+ - NCT06477042Recruiting
Act on quality of life in patients with aortic stenosis
This trial studies how a TAVI procedure affects the quality of life of people with aortic stenosis, especially those with multiple health conditions. It may help doctors understand how this treatment improves daily living for patients like you.
Clermont-FerrandAges 18 years+ - NCT06781502Recruiting
Liver Disease and Transplant Study
This study is creating a database of people with severe liver problems or who have had a liver transplant. The goal is to learn more about these conditions and improve care.
Bologna, BolognaAges 18 years+ - NCT07474363Recruiting
Depression differences between men and women
This study looks at how depression affects men and women differently, including symptoms, strength to cope (resilience), and feelings of stigma. It aims to understand these differences to improve treatment.
Eskişehir, EskişehirAges 18–65 - NCT06702124RecruitingPhase 3
Rotigotine patch with rivastigmine for mild to moderate Alzheimer's
This trial tests if adding a rotigotine patch to your usual rivastigmine treatment can help with symptoms of Alzheimer's. It is for people with mild to moderate Alzheimer's who have been stable on rivastigmine for at least 3 months.
Rome, ItalyAges 50–85 - NCT07471659Recruiting
Daily supplement for stress relief in older adults
This study tests whether a daily supplement called Humiome® Post LB can help men and women aged 50–75 who feel moderately stressed feel better overall. It involves taking the supplement and completing surveys on your phone or computer for several weeks.
Saint-HerblainAges 50–75 - NCT07465432RecruitingPhase 4
Cefiderocol study in burn injury patients
This trial tests how the antibiotic cefiderocol works in burn patients. It aims to ensure the drug is safe and effective for treating infections in people with severe burns.
Memphis, TennesseeAges 18–80
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,471 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.